Inhibiting proliferation of gefitinib-resistant, non-small cell lung cancer

被引：0
|
作者：
Makoto Sudo
Tan Min Chin
Seiichi Mori
Ngan B. Doan
Jonathan W. Said
Makoto Akashi
H. Phillip Koeffler
机构：
[1] National University of Singapore,Cancer Science Institute
[2] National University Hospital,Department of Hematology and Oncology
[3] The Cancer Institute,Department of Cancer Genomics
[4] Japanese Foundation for Cancer Research,Department of Pathology and Laboratory Medicine
[5] University of California,Research Center for Radiation Emergency
[6] National Institute of Radiological Sciences,Division of Hematology and Oncology
[7] Cedars-Sinai Medical Center,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2013年 / 71卷
关键词：
Non-small cell lung cancer (NSCLC); Tyrosine kinase inhibitor (TKI); EGFR; 17-DMAG; Belinostat; Combination chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：1325 / 1334
页数：9
相关论文
共 50 条
  • [11] Overexpression and extended degradation rate of Axl in acquired gefitinib-resistant non-small cell lung cancer cells
    Kim, Donghwa
    Bach, Duc-Hiep
    Hong, Ji-Young
    Park, Hyen Joo
    Lee, Sang Kook
    CANCER RESEARCH, 2018, 78 (13)
  • [12] The role of salvage surgery in the treatment of a gefitinib-resistant non-small cell lung cancer patient: a case report
    Zang, Jing
    Horinouchi, Hidehito
    Hanaoka, Jun
    Funai, Kazuhito
    Sakakura, Noriaki
    Liao, Hu
    JOURNAL OF THORACIC DISEASE, 2021, 13 (07) : 4554 - 4559
  • [13] Role of adenosine A2a receptors in the growth control of a gefitinib-resistant non-small cell lung cancer cell growth
    Noguchi, Maki
    Kuzumaki, Naoko
    Nagasawa, Atsumi
    Narita, Michiko
    Narita, Minoru
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2013, 121 : 197P - 197P
  • [14] Combination Effect between Bortezomib and Tumor Necrosis Factor α on Gefitinib-resistant Non-small Cell Lung Cancer Cell Lines
    Kusumoto, Sojiro
    Sugiyama, Tomohide
    Ando, Koichi
    Hosaka, Takamichi
    Ishida, Hiroo
    Shirai, Takao
    Yamaoka, Toshimitsu
    Okuda, Kentaro
    Hirose, Takashi
    Ohnishi, Tsukasa
    Inoue, Fumiko
    Kanome, Tomoko
    Kadofuku, Tsuyoki
    Saijo, Nagahiro
    Adachii, Mitsuru
    Ohmori, Tohru
    ANTICANCER RESEARCH, 2009, 29 (06) : 2315 - 2322
  • [15] Deoxypodophyllotoxin Inhibits Cell Growth and Induces Apoptosis by Blocking EGFR and MET in Gefitinib-Resistant Non-Small Cell Lung Cancer
    Kim, Han Sol
    Oh, Ha-Na
    Kwak, Ah-Won
    Kim, Eunae
    Lee, Mee-Hyun
    Seo, Ji-Hye
    Cho, Seung-Sik
    Yoon, Goo
    Chae, Jung-Il
    Shim, Jung-Hyun
    JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 2021, 31 (04) : 559 - 569
  • [16] Short-hairpin RNA library: identification of therapeutic partners for gefitinib-resistant non-small cell lung cancer
    Sudo, Makoto
    Mori, Seiichi
    Madan, Vikas
    Yang, Henry
    Leong, Geraldine
    Koeffler, H. Phillip
    ONCOTARGET, 2015, 6 (02) : 814 - 824
  • [17] Targeting the degradation of AXL receptor tyrosine kinase to overcome resistance in gefitinib-resistant non-small cell lung cancer
    Bae, Song Yi
    Hong, Ji-Young
    Lee, Hye-Jung
    Park, Hyen Joo
    Lee, Sang Kook
    ONCOTARGET, 2015, 6 (12) : 10146 - 10160
  • [18] Antitumor Impact of p14ARF on Gefitinib-Resistant Non-Small Cell Lung Cancers
    Saito, Ken
    Takigawa, Nagio
    Ohtani, Naoko
    Iioka, Hidekazu
    Tomita, Yuki
    Ueda, Ryuzo
    Fukuoka, Junya
    Kuwahara, Kazuhiko
    Ichihara, Eiki
    Kiura, Katsuyuki
    Kondo, Eisaku
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (08) : 1616 - 1628
  • [19] Gefitinib in non-small cell lung cancer
    Tamura, K
    Fukuoka, M
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (06) : 985 - 993
  • [20] Chemical Synthesis of Novel DDR1 Inhibitors and Their Activity Against Gefitinib-Resistant Non-Small Cell Lung Cancer
    Xuemei Xu
    Siyu Chen
    Doudou Sun
    Xuebao Wang
    Zhouyang Xu
    Russian Journal of Bioorganic Chemistry, 2025, 51 (1) : 285 - 297
12345